Skip to content

Clinical trials

Phase 3 Lymphoproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 3 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20051
20061
20084
20101
20111
20121
20152
20171
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology3
Acerta Pharma BV1
Amgen1
Ariad Pharmaceuticals1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Jonsson Comprehensive Cancer Center1
Mayo Clinic1
Merck Sharp & Dohme LLC1
Oncternal Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders20
Lymphoma12
Lymphoma, Non-Hodgkin10
Multiple Myeloma9
Leukemia8
Lymphoma, Large B-Cell, Diffuse8
Neoplasms, Plasma Cell8
Lymphoma, Mantle-Cell7
Hodgkin Disease6
Immunoproliferative Disorders6

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.